150 related articles for article (PubMed ID: 2141846)
1. Ovarian response in repetitive cycles induced by menotrophin alone or combined with gonadotrophin releasing hormone analogue.
Ron-El R; Raziel A; Herman A; Golan A; Nahum H; Soffer Y; Caspi E
Hum Reprod; 1990 May; 5(4):427-30. PubMed ID: 2141846
[TBL] [Abstract][Full Text] [Related]
2. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
3. The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization.
Bassil S; Wyns C; Toussaint-Demylle D; Nisolle M; Gordts S; Donnez J
Hum Reprod; 1997 Jun; 12(6):1240-5. PubMed ID: 9222009
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.
Golan A; Herman A; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1994 Sep; 9(9):1631-3. PubMed ID: 7836512
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
7. The impact of the refractory period to gonadotropin therapy in IVF-ET cycles post longacting gonadotropin-releasing hormone (GNRH) analogue.
Ashkenazi J; Goldman GA; Dicker D; Feldberg D; Shelef M; Goldman JA
Eur J Obstet Gynecol Reprod Biol; 1991 Mar; 39(1):37-40. PubMed ID: 1827627
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
Yang TS; Wang BC; Chang SP; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
[TBL] [Abstract][Full Text] [Related]
11. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
13. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
[TBL] [Abstract][Full Text] [Related]
15. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
[TBL] [Abstract][Full Text] [Related]
16. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone.
Ron-El R; Herman A; Golan A; Soffer Y; Nachum H; Caspi E
Fertil Steril; 1992 Dec; 58(6):1164-8. PubMed ID: 1459267
[TBL] [Abstract][Full Text] [Related]
17. [Combined GnRH analogs/hMG/hCG treatment].
Braendle W
Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
[TBL] [Abstract][Full Text] [Related]
18. The use of a long-acting gonadotropin-releasing hormone analog(D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs.
Yang YS; Ho HN; Lien YR; Hwang JL; Melinda S; Lin HR; Lee TY
J Formos Med Assoc; 1991 Nov; 90(11):1081-5. PubMed ID: 1687055
[TBL] [Abstract][Full Text] [Related]
19. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
[TBL] [Abstract][Full Text] [Related]
20. Women with one ovary have decreased response to GnRHa/HMG ovulation protocol in IVF but the same pregnancy rate as women with two ovaries.
Lass A; Paul M; Margara R; Winston RM
Hum Reprod; 1997 Feb; 12(2):298-300. PubMed ID: 9070715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
